Pfizer JKI 5 (Xeljanz 5 mg)
Generic Name: tofacitinib
Pill imprint Pfizer JKI 5 has been identified as Xeljanz 5 mg.
Xeljanz is used in the treatment of rheumatoid arthritis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Xeljanz 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about Xeljanz (tofacitinib)
- Other brands: Xeljanz XR
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.